Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems
- 1 December 2013
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 122 (6), 1205-1213
- https://doi.org/10.1097/aog.0000000000000019
Abstract
To evaluate the efficacy and safety of two low-dose levonorgestrel intrauterine contraceptive systems. Nulliparous and parous women aged 18-35 years with regular menstrual cycles (21-35 days) requesting contraception were randomized to 3 years of treatment with one of two levonorgestrel intrauterine contraceptive systems: 13.5 mg total content or 19.5 mg total content. The primary outcome was the pregnancy rate, calculated as the Pearl Index. Overall, 1,432 and 1,452 women in the 13.5 mg intrauterine contraceptive system and 19.5 mg intrauterine contraceptive system groups, respectively, had a placement attempted and were included in the full analysis set to evaluate efficacy and safety. Mean (standard deviation) age was 27.1 (4.8) years; 39.2% were nulliparous. Over the 3-year study period, 0.33 pregnancies per 100 women-years (95% confidence interval [CI] 0.16-0.60) were observed with the 13.5 mg intrauterine contraceptive system compared with 0.31 per 100 women-years (95% CI 0.15-0.57) with the 19.5 mg intrauterine contraceptive system. Kaplan-Meier estimates for that period were 0.009 and 0.010, respectively. At least partial expulsions occurred in 4.56% and 3.58% and discontinuation rates resulting from a reported adverse event occurred in 21.9% and 19.1%, respectively. Ten of the 20 pregnancies were ectopic. Serious adverse events included six cases of pelvic inflammatory disease and one partial uterine perforation. Both lower-dose levonorgestrel intrauterine contraceptive systems were highly effective for 3 years of use and generally well tolerated. ClinicalTrials.gov, www.clinicaltrials.gov, NCT00528112. : I.Keywords
This publication has 11 references indexed in Scilit:
- Failed IUD insertions in community practice: an under-recognized problem?Contraception, 2012
- Health Care Provider Attitudes and Practices Related to Intrauterine Devices for Nulliparous WomenObstetrics & Gynecology, 2012
- A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and MirenaFertility and Sterility, 2012
- Recent developments in the clinical use of the levonorgestrel‐releasing intrauterine systemActa Obstetricia et Gynecologica Scandinavica, 2011
- Practice Bulletin No. 121: Long-Acting Reversible Contraception: Implants and Intrauterine DevicesObstetrics & Gynecology, 2011
- Population-Based Ectopic Pregnancy Trends, 1993–2007American Journal of Preventive Medicine, 2011
- Length of the endometrial cavity as measured by uterine sounding and ultrasonography in women of different paritiesContraception, 2010
- Use of the Mirena™ LNG-IUS and Paragard™ CuT380A intrauterine devices in nulliparous womenContraception, 2010
- Subject and clinician experience with the levonorgestrel-releasing intrauterine systemContraception, 2008
- Sample Size Calculation for Clinical Studies on the Efficacy of a New Contraceptive MethodBiometrical Journal, 2004